Abstract
Mice that are genetically deficient in UDP-galactose: ceramide galactosyltransferase are unable to synthesize galactosylceramide. Consequently, sulfatide, which can be synthesized only by sulfation of galactosylceramide, is also totally absent in affected mouse brain. α-Hydroxy fatty acid-containing glucosylceramide partially replaces the missing galactosylceramide. A substantial proportion of sphingomyelin, which normally contains only non-hydroxy fatty acids, also contains α-hydroxy fatty acids. These findings indicate that α-hydroxy fatty acid-containing ceramide normally present only in galactosylceramide and sulfatide is diverted to other compounds because they cannot be synthesized into galactosylceramide due to the lack of the galactosyltransferase. We have examined brain gangliosides in order to determine if α-hydroxy fatty acid-containing glucosylceramide present in an abnormally high concentration is also incorporated into gangliosides. The brain ganglioside composition, however, is entirely normal in both the total amount and molecular distribution in these mice. One feasible explanation is that UDP-galactose: glucosylceramide galactosyltransferase does not recognize α-hydroxy fatty acid-containing glucosylceramide as acceptor. This analytical finding is consistent with the relative sparing of gray matter in the affected mice and provides an insight into sphingolipid metabolism in the mouse brain.
Similar content being viewed by others
REFERENCES
Morell, P., and Radin, N.S. 1969. Synthesis of cerebroside by brain from uridine diphosphate galactose and ceramide containing hydroxy fatty acid. Biochemistry. 8:506-512.
Costantino-Ceccarini, E., and Morell, P. 1972. Biosynthesis of brain sphingolipids and myelin accumulation in the mouse. Lipids. 7:656-659.
Schaeren-Wiemers, N., Van der Bijl, P., and Schwab, M.E. 1995. The UDP-galactose:ceramide galactosyltransferase: Expression pattern in oligodendrocytes and schwann cells during myelination and substrate preference for hydroxyceramide. J. Neurochem. 65:2267-2278.
Schulte, S., and Stoffel, W. 1993. Ceramide UDPgalactosyltransferase from myelinating rat brain: Purification, cloning, and expression. Proc. Natl. Acad. Sci., USA. 90:10265-10269.
Stahl, N., Jurevics, H., Morell, P., Suzuki, K., and Popko, B. 1994. Isolation, characterization, and expression of cDNA clones that encode rat UDP-galactose:ceramide galactosyltransferase. J. Neurosci. Res. 38:234-242.
Coetzee, T., Fujita, N., Dupree, J., Shi, R., Blight, A., Suzuki, K., and Popko, B. 1996. Myelination in the absence of galactocerebroside and sulfatide: Normal structure with abnormal function and regional instability. Cell. 86:209-219.
Bosio, A., Binczek, E., Haupt, W.F., and Stoffel, W. 1998. Composition and biophysical properties of myelin lipid define the neurological defects in galactocerebroside-and sulfatide-deficient mice. J. Neurochem. 70:308-315.
Bosio, A., Binczek, E., and Stoffel, W. 1996. Functional break-down of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis. Proc. Natl. Acad. Sci. USA. 93:13280-13285.
Dupree, J.L., Coetzee, T., Blight, A., Suzuki, K., and Popko, B. 1998. Myelin galactolipids are essential for proper node of Ranvier formation in the CNS. Journal of Neuroscience. 18:1642-1649.
Svennerholm, L., and Fredman, P. 1980. A procedure for the quantitative isolation of brain gangliosides. Biochim. Biophys. Acta 617:97-109.
Svennerholm, L., Boström, K., Helander, C.G., and Jungbjer, B. 1991. Membrane lipids in the aging human brain. J. Neurochem. 56:2051-2059.
Wells, M.A., and Dittmer, J.C. 1963. The use of Sephadex for the removal of non-lipid contaminants from lipid extracts. Biochemistry. 2:1259-1263.
Svennerholm, L. 1957. Estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochim. Biophys. Acta. 24:604-611.
Miettinen, T., and Takki-Luukkainen, I.-T. 1959. Use of butylacetate for determination of sialic acid. Acta Chem. Scand: 13:856-858.
Van der Bijl, P., Strous, G.J., Lopes-Cardozo, M., Thomas-Oates, J., and Van Meer, G. 1996. Synthesis of non-hydroxy-galactosylceramides and galactosyldiglycerides by hydroxy-ceramide galactosyltransferase. Biochem. J. 317:589-597.
Suzuki, K., Poduslo, S.E., and Norton, W.T. 1967. Gangliosides in the myelin fraction of developing rats. Biochim. Biophys. Acta. 144:375-381.
Suzuki, K., Poduslo, J.F., and Poduslo, S.E. 1998. Further evidence for a specific ganglioside fraction closely associated with myelin. Biochim. Biophys. Acta. 152:576-586.
Hildebrand, J., Stoffyn, P., and Hauser, G. 1970. Biosynthesis of lactosylceramide by rat brain preparations and comparison with the formation of ganglioside GM1 and psychosine during development. J. Neurochem. 17:403-411.
Nomura, T., Takizawa, M., Wakisaka, E., Hattori, M., Inoue, K., Arai, H., and Matsuo, N. 1997. Purification and characterization of lactosylceramide synthase. Glycoconjugate J. 14:S51 (Abst. PO16, #63).
Stoffel, W., and Bosio, A. 1997. Myelin glycolipids and their functions. Curr. Opin. Neurobiol. 7:654-661.
Coetzee, T., Suzuki, K., and Popko, B. 1998. New perspectives on the function of myelin galactolipids. Trends Neurosci. 21:126-130.
Suzuki, K., Vanier, M.T., and Suzuki, K. 1998. Induced mouse models of abnormal sphingolipid metabolism. J. Biochem. 124:8-19.
Yu, R.K., and Yen, S.I. 1975. Gangliosides in developing mouse brain myelin. J. Neurochem. 25:229-232.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Suzuki, K., Vanier, M.T., Coetzee, T. et al. Drastically Abnormal Gluco- and Galactosylceramide Composition Does Not Affect Ganglioside Metabolism in the Brain of Mice Deficient in Galactosylceramide Synthase. Neurochem Res 24, 471–474 (1999). https://doi.org/10.1023/A:1022571410445
Issue Date:
DOI: https://doi.org/10.1023/A:1022571410445